ITCI
Intra-Cellular Therapies Inc.
ITCI
ITCI
Delisted
ITCI was delisted on the 1st of April, 2025.
187 hedge funds and large institutions have $2.72B invested in Intra-Cellular Therapies Inc. in 2021 Q2 according to their latest regulatory filings, with 31 funds opening new positions, 57 increasing their positions, 68 reducing their positions, and 14 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding in top 10
Funds holding in top 10: →
more capital invested
Capital invested by funds: $ → $
10% more funds holding
Funds holding: 170 → 187 (+17)
16% less repeat investments, than reductions
Existing positions increased: 57 | Existing positions reduced: 68
Holders
187
Holding in Top 10
3
Calls
$39M
Puts
$11.4M
Top Buyers
| 1 | +$10.9M | |
| 2 | +$10.7M | |
| 3 | +$9.19M | |
| 4 |
Franklin Resources
San Mateo,
California
|
+$8.01M |
| 5 |
BGIM
Brandywine Global Investment Management
Philadelphia,
Pennsylvania
|
+$7.98M |
Top Sellers
| 1 | -$17.9M | |
| 2 | -$14M | |
| 3 | -$9.98M | |
| 4 |
SC
Samlyn Capital
New York
|
-$9.88M |
| 5 |
Adage Capital Partners
Boston,
Massachusetts
|
-$8.16M |